Gold
CSL Behring's portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Children's Hospital of Philadelphia (CHOP) is the nation's first hospital devoted exclusively to the care of children. Since our start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic firsts in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives. Today, families facing complex conditions come to CHOP from all over the world, and our compassionate care and innovation has repeatedly earned us a top spot on the U.S. News & World Report's Honor Roll of the nation's best children's hospitals.
Children’s National Hospital is a leading pediatric health system located in the heart of Washington, DC. Serving children since 1870, Children’s National houses over 600 Pediatric physician experts across 60 specialties, and it is home to the Sheikh Zayed Campus for Advanced Children’s Medicine. Proudly named #1 in Neonatology for the fourth consecutive year and one of the top 10 pediatric hospitals nationally by U.S. News & World Report 2020-21, in addition to 7 specialties ranked in the top 10 for the tenth straight year. Thousands of patients are welcomed every year to the Global Services Division, treating children across 20 countries around the world with in-country liaisons in Kuwait and the United Arab Emirates.
Cincinnati Children's ranks among the top five in the nation in U.S. News & World Report's 2021-22 listing of Best Children's Hospitals. A nonprofit, academic medical center established in 1883, Cincinnati Children's is one of the top three recipients of pediatric research grants from the National Institutes of Health. The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education, and innovation. Additional information about technologies developed at Cincinnati Children's may be found at Innovation.CincinnatiChildrens.org
Kyowa Hakko Kirin is a research-based life sciences company with special strengths in biotechnology. We are opening up the path toward the development of new biologics, and developing new medicines to meet medical needs that are currently not being satisfied by existing pharmaceuticals.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. Novartis Group companies employ approximately 118,000 full-time-equivalent associates.
Who we are? We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 45,000 people in 80 offices around the world, and market our products in 169 countries. More briefed (if needed): "Founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases."
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.
Great Ormond Street Hospital for Children (GOSH) in London is a globally renowned paediatric hospital, championing innovation and providing ground-breaking treatments for children with rare and complex conditions. Our pioneering research gives new hope to children and families from around the world. With over 60 paediatric specialties we are the largest UK centre for cardiology/cardiothoracic surgery, bone marrow transplant, neurosurgery, nephrology, intensive care, craniofacial reconstruction, and gene therapy. We are also the largest centre in Europe for children’s cancer and epilepsy. Our expert teams of clinicians deliver 360-degree, multi-specialty care with the child at the centre.